Pedicle flap coverage for infected ventricular assist device augmented with dissolving antibiotic beads: Creation of an antibacterial pocket.
Sasha Anne StillRene P MyersJose TallajSalpy PamboukianWilliam HolmanJames DaviesCharles W HoopesErik Orozco-HernandezPublished in: Journal of cardiac surgery (2020)
Infectious complications following left ventricular assist device implantation can carry significant morbidity and mortality. The main tenet of treatment is source control which entails local wound care, intravenous antimicrobial therapy, surgical debridement, and at times, soft tissue flap coverage. The mode of therapy depends on the severity, etiology, and location of infection as well as the clinical status of the patient. We describe a case of a 46-year-old male who underwent left ventricular assist device placement complicated by pump thrombosis, recurrent infection, and hardware exposure who was successfully treated with a novel method of staged, soft tissue reconstruction.
Keyphrases
- left ventricular assist device
- soft tissue
- affordable care act
- healthcare
- palliative care
- pulmonary embolism
- minimally invasive
- staphylococcus aureus
- high dose
- left ventricular
- case report
- stem cells
- quality improvement
- robot assisted
- pain management
- breast reconstruction
- low dose
- atrial fibrillation
- chronic pain
- replacement therapy
- bone marrow
- virtual reality
- catheter ablation